Mostrar el registro sencillo del ítem

dc.contributor.authorUgalde, Alejandro P
dc.contributor.authorBretones, Gabriel
dc.contributor.authorRodríguez, David
dc.contributor.authorQuesada, Víctor
dc.contributor.authorLlorente, Francisco
dc.contributor.authorFernández-Delgado, Raúl
dc.contributor.authorJiménez-Clavero, Miguel Ángel
dc.contributor.authorVazquez, Jesus 
dc.contributor.authorCalvo, Enrique 
dc.contributor.authorTamargo-Gómez, Isaac
dc.contributor.authorMariño, Guillermo
dc.contributor.authorRoiz-Valle, David
dc.contributor.authorMaeso, Daniel
dc.contributor.authorAraujo-Voces, Miguel
dc.contributor.authorEspañol, Yaiza
dc.contributor.authorBarceló, Carles
dc.contributor.authorFreije, José Mp
dc.contributor.authorLópez-Soto, Alejandro
dc.contributor.authorLópez-Otín, Carlos
dc.date.accessioned2022-12-09T10:49:10Z
dc.date.available2022-12-09T10:49:10Z
dc.date.issued2022-11-02
dc.identifier.citationEMBO J. 2022 Nov 2;41(21):e110727es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15263
dc.description.abstractBetter understanding on interactions between SARS-CoV-2 and host cells should help to identify host factors that may be targetable to combat infection and COVID-19 pathology. To this end, we have conducted a genome-wide CRISPR/Cas9-based loss-of-function screen in human lung cancer cells infected with SARS-CoV-2-pseudotyped lentiviruses. Our results recapitulate many findings from previous screens that used full SARS-CoV-2 viruses, but also unveil two novel critical host factors: the lysosomal efflux transporter SPNS1 and the plasma and lysosomal membrane protein PLAC8. Functional experiments with full SARS-CoV-2 viruses confirm that loss-of-function of these genes impairs viral entry. We find that PLAC8 is a key limiting host factor, whose overexpression boosts viral infection in eight different human lung cancer cell lines. Using single-cell RNA-Seq data analyses, we demonstrate that PLAC8 is highly expressed in ciliated and secretory cells of the respiratory tract, as well as in gut enterocytes, cell types that are highly susceptible to SARS-CoV-2 infection. Proteomics and cell biology studies suggest that PLAC8 and SPNS1 regulate the autophagolysosomal compartment and affect the intracellular fate of endocytosed virions.es_ES
dc.description.sponsorshipWe thank Marisa Arias and Luis Enjuanes for their support and suggestions. We thank Xose S. Puente, Xurde M. Caravia, Alicia R. Folgueras, Pedro M. Quir os, and Manuel Illescas for their helpful advice and comments on the manuscript. We thank Mar ıa Dolores Chiara for technical support. We thank Marta Alonso Guerv os, Ana Salas Bustamante, Jos e Luis Mart ınez Fern andez, Daniel Serna Fuente, and Marcos Garc ıa Ocana from the microscopy, cytome- ~ try, sequencing, and cell-culture core facilities of the University of Oviedo for their technical support. We thank Ignacio Varela and Juana Mar ıa Garc ıa Pedrero for sharing reagents. This work was supported by Instituto de Salud Carlos III(COV20/00652, MS19/00100, PI20/01267, COV20/00571 and PT17/ 0019/0003), Ministerio de Ciencia e Innovacion (Spain) (PDI 2020-118394RB100, SAF2017-87655-R, PID2021-127534OB-100, and PGC2018-097019-B-I00), “laCaixa” Banking Foundation (HR17-00247) and Consejer ıa de Ciencia, Innovacion y Universidad del Gobierno del Principado de Asturias (AYUD/ 2021/ 57167). D.R.V and D.M are supported by PhD fellowships from Ministerio de Ciencia e Innovacion(Spain).es_ES
dc.language.isoenges_ES
dc.publisherEMBO Press es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshCOVID-19es_ES
dc.subject.meshLung Neoplasms es_ES
dc.subject.meshHumans es_ES
dc.subject.meshSARS-CoV-2es_ES
dc.subject.meshAngiotensin-Converting Enzyme 2es_ES
dc.subject.meshLysosome-Associated Membrane Glycoproteins es_ES
dc.subject.meshAutophagy es_ES
dc.subject.meshProteins es_ES
dc.titleAutophagy-linked plasma and lysosomal membrane protein PLAC8 is a key host factor for SARS-CoV-2 entry into human cells.es_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID36124427es_ES
dc.format.volume41es_ES
dc.format.number21es_ES
dc.format.pagee110727es_ES
dc.identifier.doi10.15252/embj.2022110727es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.contributor.funderMinisterio de Ciencia e Innovación (España) es_ES
dc.contributor.funderFundación La Caixa es_ES
dc.contributor.funderGobierno del Principado de Asturias (España) es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1460-2075es_ES
dc.relation.publisherversion10.15252/embj.2022110727es_ES
dc.identifier.journalThe EMBO journales_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Proteómica cardiovasculares_ES
dc.repisalud.institucionCNICes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/COV20/00652es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/MS19/00100es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI20/01267es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/COV20/00571es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PT17/0019/0003es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/DI/2020-118394RB100es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/SAF2017-87655-Res_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2021-127534OB-100es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PGC2018-097019-B-I00es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/HR17-00247es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/AYUD/2021/57167es_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional